February 18, 2026

FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer

FDA: Device Delivers Non-invasive Therapy and Supports Care at Home White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with locally advanced pancreatic...

recent articles

Singapore, Helsinki – Aiforia, a leading software company providing artificial intelligence (AI) solutions for medical image analysis, and X-ZELL, a clinical stage med-tech company aiming to make early, affordable cancer detection accessible...

We are excited to announce Leica Biosystems has partnered with Cell IDx, a technology leader in multiplexed cellular immunodiagnostic to accelerate the discovery journey in cancer research. Cell IDx develops highly sensitive and specific...

United Kingdom, 22 April 2021 - A test which uses artificial intelligence (AI) to measure proteins present in some patients with advanced bowel cancer could hold the key to more targeted treatment, according to research...

  Keynote Speakers Jeroen van der Laak, PhD, Radboud University Medical Center “Steady Progress with Realizing Clinical-Grade AI for Histopathological Diagnosis: The European Experience” Darren Treanor, MD, University of...

OR

platinum partners

gold partners

Silver Partners

Media Partners